Ptc Therapeutics (PTCT) EBT (2012 - 2026)

Ptc Therapeutics' EBT history runs 15 years deep, the most recent figure standing at -$2.5 million for Q1 2026.

• In Q1 2026, EBT fell 100.26% year-over-year to -$2.5 million; the TTM figure through Mar 2026 stood at -$1.5 billion (down 328.04% YoY), while the FY2025 annual figure was -$553.2 million, down 52.35% from the prior year.
• EBT was -$2.5 million for Q1 2026 at Ptc Therapeutics, up from -$1.4 billion in the prior quarter.
• In the past five years, EBT ranged from a high of $929.8 million in Q1 2025 to a low of -$1.4 billion in Q4 2025.
• Historically, EBT has averaged -$83.6 million across 5 years, with a median of -$98.0 million in 2024.
• Biggest YoY gain for EBT was 1197.84% in 2025; the steepest drop was 1366.65% in 2025.
• A 5-year view of EBT shows it stood at -$193.3 million in 2022, then jumped by 424.67% to $627.7 million in 2023, then plunged by 115.09% to -$94.7 million in 2024, then sank by 1366.65% to -$1.4 billion in 2025, then surged by 99.82% to -$2.5 million in 2026.
• The last three EBT figures came in at -$2.5 million (Q1 2026), -$1.4 billion (Q4 2025), and -$23.1 million (Q3 2025), per Business Quant data.